Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    Nature communications · 2022
    WLWodan Ling
    PMID: 36109499PMCID: PMC9477887DOIFirst author127 citations
  2. 2
    Bioinformatics (Oxford, England) · 2024
    JRJohn Richard LeeWLWodan Ling
    PMID: 39404767PMCID: PMC11639162DOISenior author
  3. 3
    Microbiome · 2021
    WLWodan Ling
    PMID: 34474689PMCID: PMC8414689DOIFirst author24 citations

Publications

30 publications

Funding

10 grantsView NIH portfolio on RePORTER ↗

Active

9 grants
  • Co-I
    Development of An Integrated Pipeline for Early PD Prediction and Disease Modifying Drug Repurposing
    National Institute of Neurological Disorders and Stroke · 2026–2031
    R01NS148533-01
  • Co-I
    Progression Subtyping and Drug Target Identification for Parkinson's Disease with Integrative Machine Learning
    National Institute of Neurological Disorders and Stroke · 2024–2029
    R01NS140142-01
  • PI
    Robust Statistical Methods for Longitudinal Microbiome Studies
    National Institute of General Medical Sciences · 2024–2029
    R01GM155734-03
  • Co-I
    Gut microbial beta-glucuronidases as a biomarker for mycophenolic acid enterohepatic recirculation and associated toxicities
    National Institute of Diabetes and Digestive and Kidney Diseases · 2024–2029 · via University of Pennsylvania· 2 renewals
    R01DK139249-03
  • Co-I
    Data-Driven Approach to Identify Determinants of Outcomes and Risk Factors of Cardiovascular Diseases in New York City Area
    Novartis Foundation · 2023–2027
    NF 231850-01
  • Sub-PI
    Statistical Methods for Enhanced Mapping of Microbiome Relationships
    National Institute of General Medical Sciences · 2023–2027 · via Fred Hutchinson Cancer Center
    R01GM151301-04
  • Co-I
    Microbial Biomarkers for Diagnosing and Predicting Infections in Kidney Transplant Recipients
    National Institutes of Health · 2024–2027 · via University of Pennsylvania· 2 renewals
    R01AI184528-03
  • Co-I
    Pre-malignant mutation landscape and risk factors for progression to hematologic cancers
    National Cancer Institute · 2021–2027
    R01CA248747-01A1
  • Sub-PI
    Novel, automated mobile heart rhythm analysis technology to start antiarrhythmic medications safely at home
    National Heart, Lung, and Blood Institute · 2025–2026 · via SafeBeat Rx Inc.
    R44HL167294-02
Completed grants (1)
  • Co-I
    Characterizing and Predicting Patient Trajectories After Live Discharge from Hospice among Older Adults with Alzheimer's Disease and Related Dementias
    National Institute on Aging · 2024–2025
    R56AG085541-01A1

Mentoring

1 mentee

External relationships

Other

MetaboliteDx Corp.